Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,654.16 -805.40 (-1.31%) CMC Crypto 200
1,260.92 -22.91 (-1.78%)
LivaNova PLC (LIVN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 54.83 |
| Open | 55.27 |
| Bid | 54.69 x 100 |
| Ask | 54.84 x 200 |
| Day's range | 54.43 - 55.31 |
| 52-week range | 42.75 - 64.47 |
| Volume | |
| Avg. volume | 658,593 |
| Market cap | 2.969B |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
LivaNova to Announce Second-Quarter 2024 Results
LONDON, June 18, 2024--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call.
- Business Wire
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
LONDON, June 06, 2024--LivaNova announced preliminary results for the unipolar cohort of the RECOVER study, assessing use of VNS Therapy in treatment-resistant depression.
- Business Wire
LivaNova to Present at the Goldman Sachs Healthcare Conference
LONDON, May 23, 2024--LivaNova announced Vladimir Makatsaria, CEO, will present a fireside chat at the Goldman Sachs Conference in Miami, Florida at 1:20 pm ET on June 10.
© 2024 Yahoo. All rights reserved.